MALO - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
N1T-MC-MALO : A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01; N1T-MC-RT01
Principal Investigator
Anastasia-Stefania Alexopoulos, MBBS, MHS
Endocrinologist
Protocol Number
IRB:
PRO00119396
NCT:
NCT07165028
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment